Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Congcong Tan"'
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-16 (2023)
Abstract Background Triple negative breast cancer (TNBC) represents a significant clinical challenge. Chemotherapy remains the mainstay for a large part of TNBC patients, whereas drug resistance and tumor recurrence frequently occur. It is in urgent
Externí odkaz:
https://doaj.org/article/92a5e08a19c24a24943b9ec17a0c687e
Publikováno v:
npj Precision Oncology, Vol 7, Iss 1, Pp 1-14 (2023)
Abstract Patients with triple-negative breast cancer (TNBC) have a poor prognosis and high relapse rate due to limited therapeutic options. This study was conducted to determine the mechanisms of action of panobinostat, a pan-inhibitor of histone dea
Externí odkaz:
https://doaj.org/article/18cc9a8b53da404d8c53f4726ee4620b
Publikováno v:
Biological Procedures Online, Vol 25, Iss 1, Pp 1-12 (2023)
Abstract Background Resistance to HER2-targeted therapies, including the monoclonal antibody trastuzumab and tyrosine kinase inhibitor lapatinib, frequently occurs and currently represents a significant clinical challenge in the management of HER2-po
Externí odkaz:
https://doaj.org/article/62f9c571f0c14e239d9e13d96287d03f
Publikováno v:
Asian Journal of Surgery, Vol 46, Iss 12, Pp 5858-5859 (2023)
Externí odkaz:
https://doaj.org/article/e83ac2660aeb4fd2aa71d71fc50eb95f
Autor:
Zhichao Fan, Xiang Zhao, Yan Dong, Jie Zhou, Yingxue Li, Junyi Wang, Yuchen Qi, Congcong Tan, Hua Yu, Jianjun Li
Publikováno v:
International journal of biological macromolecules. 223
MicroRNAs (miRNAs), useful biomarkers for cancer diagnosis, play an important role in tumorigenesis and progression, but many of the current analysis methods can suffer from excessive protease dependence, being time-consuming and unsatisfactory perfo
Publikováno v:
Cancer Research. 82:3272-3272
Introduction: Histone deacetylases (HDACs) are dysregulated in human cancers, making them a valuable therapeutic target. The pan-HDAC inhibitor (HDACi) panobinostat is an approved anticancer drug for patients with multiple myeloma. It has been shown
Publikováno v:
Cancer Research. 82:1790-1790
Introduction: HER2-targeted therapies, including the monoclonal antibody (Ab) herceptin and the tyrosine kinase inhibitor (TKI) lapatinib, have been commonly used to treat HER2-positive breast cancer (BC). However, resistance to herceptin and/or lapa
Publikováno v:
Cancer Research. 82:2969-2969
Introduction: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with high rate of recurrence and refractoriness due to lack of well-defined molecular targets. Human epidermal growth factor receptor 3 (HER3) is differentia
Publikováno v:
Journal of Nanoscience and Nanotechnology. 15:4604-4607
The optical and structural properties of InGaN/GaN multi-quantum wells (MQWs) grown on sapphire by metalorganic chemical vapor deposition (MOCVD) have been investigated by optical measure- ments of photoluminescence (PL), and structural analysis meth
Publikováno v:
Genes, Vol 14, Iss 4, p 897 (2023)
The rare ginsenoside Compound K (CK) is an attractive ingredient in traditional medicines, cosmetics, and the food industry because of its various biological activities. However, it does not exist in nature. The commonly used method for the productio
Externí odkaz:
https://doaj.org/article/559f13f82d0841ebbafc316753598d03